Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Evonik Industries AG has the Financial Strength Rank of 5.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.
A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.
Evonik Industries AG's Interest Coverage for the quarter that ended in Jun. 2026 was 2.93.
Evonik Industries AG's debt to revenue ratio for the quarter that ended in Jun. 2026 was 0.00.
As of today, Evonik Industries AG's Altman Z-Score is 1.95.
Evonik Industries AG (XSWX:EVK) Financial Strength Explanation
The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.
Evonik Industries AG has the Financial Strength Rank of 5.
Evonik Industries AG Financial Strength Related Terms
XSWX:EVK vs LIN, SHW, ECL: Financial Strength Comparison
For the Specialty Chemicals subindustry, Evonik Industries AG's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evonik Industries AG Financial Strength vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Evonik Industries AG's Financial Strength distribution charts can be found below:
* The bar in red indicates where Evonik Industries AG's Financial Strength falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Evonik Industries AG has a Z-score of 1.95, indicating it is in Grey Zones. This implies that Evonik Industries AG is in some kind of financial stress. If it is below 1.81, the company may faces bankrupcy risk.
Warning Sign:
Altman Z-score of 1.95 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evonik Industries AG (XSWX:EVK) has a Financial Strength of 5 as of Jun. 2026. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on Evonik Industries AG and its competitors. This is 29% below median its historical median of 7.00. Over the past decade, Evonik Industries AG's Financial Strength has ranged from 5.00 to 9.00.
Is Evonik Industries AG's Financial Strength too high?
Evonik Industries AG's current Financial Strength of 5 is 29% below median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 9.00. Overall, Evonik Industries AG has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Evonik Industries AG's Financial Strength compare to LIN and SHW?
Evonik Industries AG's Financial Strength of 5 can be compared against companies in the Chemicals industry. Historically, Evonik Industries AG's own Financial Strength has ranged from 5.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Financial Strength for a Chemicals company?
A good Financial Strength depends on the Chemicals industry context. However, Financial Strength should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Financial Strength mean?
A high Financial Strength can signal that a stock is expensive relative to its fundamentals. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on Evonik Industries AG and its competitors. Evonik Industries AG's current Financial Strength is 5, which is 29% below median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evonik Industries AG stock overvalued right now?
Evonik Industries AG (XSWX:EVK) has a current Financial Strength of 5. The stock's GF Value™ is CHF15.17, compared to a current price of CHF16.48 — trading 8.6% above its estimated fair value. The current Financial Strength is 5, which is 29% below median its 10-year median of 7.00. Evonik Industries AG's overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Financial Strength calculated?
Financial Strength is calculated from a company's financial statements. For Evonik Industries AG (XSWX:EVK), the current Financial Strength is 5 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evonik Industries AG (XSWX:EVK) Overvalued in 2026?
Based on GuruFocus' analysis, Evonik Industries AG stock appears to be overvalued.
The current stock price of CHF16.48 is trading 8.6% above its estimated GF Value™ of CHF15.17.
Key valuation signals for XSWX:EVK:
Financial Strength: 5 (29% below median its 10-year median of 7.00)
GF Value™: CHF15.17 vs. price of CHF16.48 (8.6% above fair value)
No single metric tells the full story. See the XSWX:EVK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evonik Industries AG is a chemicals company that develops and manufactures specialty chemicals and solutions for a wide range of industries. Its products include high-performance polymers, hydrogen peroxide, silicas, additives for coatings and adhesives, and amino acids for animal nutrition. It operates through three segments: Advanced Technologies, which focuses on technology-driven businesses such as high-performance polymers, silicas, and hydrogen peroxide; Custom Solutions, which develops additives, catalysts, and ingredients for personal care and pharmaceutical applications; and Infrastructure, which provides site-related infrastructure services and includes the Oxeno C4 chemicals business. It generates sales across Europe, Middle East & Africa, the Americas, and Asia-Pacific.
73GF Score
Get the complete analysis for XSWX:EVK
Financial Strength is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:EVK has been successfully added to your 
